News
Health agency warns of link between pregnancy complications and weight loss drugs
Health experts are raising concerns for women using popular weight loss medications, particularly GLP-1s like Wegovy, Zepbound, and Mounjaro. A UK health agency warns that these drugs could lead to unintended pregnancies and complications during pregnancy.
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
Zepbound was found to be more effective. Study participants using tirzepatide lost more weight after 72 weeks (average loss of 20.2% compared to 13.7% for semaglutide). This translates to an ...
Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.
The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...
Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...
Poison control experts say calls related to GLP-1 weight-loss drugs like Wegovy and Zepbound are rising, with symptoms like ...
Barchart on MSN5d
Eli Lilly vs. Novo Nordisk: Which Stock Is the Winner of the Weight-Loss Drug Boom?The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback